K203228 · Wright Medical · HWC · May 11, 2021 · Orthopedic
Device Facts
Record ID
K203228
Device Name
DART-FIRE EDGE Cannulated Screw System
Applicant
Wright Medical
Product Code
HWC · Orthopedic
Decision Date
May 11, 2021
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 888.3040
Device Class
Class 2
Attributes
Therapeutic
Intended Use
The DART-FIRE EDGE Cannulated Screws are indicated for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, fracture repair, and fracture fixation of foot and ankle bones appropriate for the size of the device. Screws are intended for single use only.
Device Story
DART-FIRE EDGE Cannulated Screw System consists of partially and fully threaded cannulated screws; used for bone fixation in foot and ankle procedures. Device is implanted by orthopedic surgeons in clinical/OR settings to stabilize bone segments during healing. Screws provide mechanical compression and fixation; surgeon selects appropriate diameter/length based on patient anatomy. Benefits include stabilization of fractures or osteotomies to facilitate bone union.
Clinical Evidence
No clinical data. Substantial equivalence supported by bench testing including mechanical performance (torque, pull-out) and MR safety assessments.
Technological Characteristics
Cannulated screws manufactured from titanium alloy (ASTM F136). Features include partially and fully threaded designs. Sterilization method is consistent with predicate. Mechanical testing performed per ASTM F543; MR safety testing per ASTM F2182 and ASTM F2052.
Indications for Use
Indicated for bone reconstruction, osteotomy, arthrodesis, joint fusion, fracture repair, and fracture fixation of foot and ankle bones. For single use only.
Regulatory Classification
Identification
A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.
K251555 — Ultra Compression Screw System · Pace Surgical · Nov 6, 2025
K050754 — PRECIMED CANNULATED SCREW SYSTEM · Precimed, Inc. · May 18, 2005
K092754 — SBI FOOT AND ANKLE CANNULATED SCREW SYSTEM, MODEL 100-0061 · Small Bone Innovations, Inc. · Jan 19, 2010
K050924 — MERETE DUOTHREADTM BONE SCREW · Merete Medical GmbH · May 27, 2005
K082874 — BIODRIVE CANNULATED SCREW SYSTEM · Biomet Trauma · Feb 5, 2009
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the date May 11, 2021. The text is in a simple, sans-serif font. The date is written in the standard US format, with the month first, followed by the day and year. The text is black and the background is white.
Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
Wright Medical Michael Mullins SR Regulatory Affairs Specialist 1023 Cherry Road Memphis, Tennessee 38117
Re: K203228
Trade/Device Name: DART-FIRE EDGE Cannulated Screw System Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth Or Threaded Metallic Bone Fixation Fastener Regulatory Class: Class II Product Code: HWC Dated: April 9, 2021 Received: April 12, 2021
Dear Michael Mullins:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
#### DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
# Indications for Use
510(k) Number (if known) K203228
Device Name DART-FIRE EDGE Cannulated Screw System
Indications for Use (Describe)
The DART-FIRE EDGE Cannulated Screws are indicated for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, fracture repair, and fracture fixation of foot and ankle bones appropriate for the device. Screws gre intended for single use only.
Type of Use (Select one or both, as applicable)
> Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
# CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
# *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
EF
PSC Publishing Services (301) 443-6740
{3}------------------------------------------------
#### K203228 Page 1 of 2
1023 Cherry Road Memphis, TN 38117 USA
901 867 9971 800 238 7117 wright.com
Image /page/3/Picture/3 description: The image shows the Wright logo. The logo consists of two overlapping trapezoids, one red and one orange, on the left side of the logo. To the right of the trapezoids is the word "WRIGHT" in red, and below that is the phrase "FOCUSED EXCELLENCE" in gray.
#### 510(K) SUMMARY
In accordance with the Food and Drug Administration Rule to implement provisions of the Safe Medical Devices Act of 1990 and in conformance with 21 CFR 807.92, this information serves as a Summary of Safety and Effectiveness for the use of the DART-FIRE EDGE Cannulated Screw System.
| (a)(1). Submitted By: | Wright Medical Technology, Inc.<br>1023 Cherry Road<br>Memphis, TN 38117 |
|-------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|
| Date: | October 30, 2020 |
| Contact Person: | Michael Mullins<br>Regulatory Affairs Specialist<br>Phone - (901) 867-4142<br>Fax - (901) 867-4190 |
| (a)(2). Proprietary Name: | DART-FIRE EDGE Cannulated Screw System |
| Common Name: | Bone Screw |
| Classification Name and Regulation: | Smooth or threaded metallic bone fixation<br>fastener, 21 CFR 888.3040 – Class II |
| Device Product Code, Device Panel: | HWC - Orthopedic |
| (a)(3). Predicate Device: | K082320: Wright Compression Screws<br>(primary)<br>K080850: DARCO Headless Compression<br>Screw (reference)<br>K183696: PERFORM Reverse (reference) |
# (a)(4). Device Description
The DART-FIRE EDGE Cannulated Screw System contains partially and fully threaded, cannulated screws offered in a variety of diameters and lengths. The screws are manufactured from titanium alloy (ASTM F136).
{4}------------------------------------------------
## (a)(5). INTENDED USE
The DART-FIRE EDGE Cannulated Screws are indicated for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, fracture repair, and fracture fixation of foot and ankle bones appropriate for the size of the device. Screws are intended for single use only.
### (a)(6). Technological Characteristics Comparison
The DART-FIRE EDGE Screw System is a new screw system. Compared to the legally marketed primary predicate, the subject system has identical indications, similar design features, the same sterilization method, and similar performance characteristics.
### (b)(1). Substantial Equivalence - Non-Clinical Evidence
Performance testing and analysis demonstrated substantial equivalence to the predicate device in insertion torque, removal torque, pull out, ultimate torque, yield torque strength per ASTM F543 and simulated MR Safety testing per ASTM F2182 (RF Heating/Image Artifact) and ASTM F2052 (Induced Force/Torques).
# (b)(2). Substantial Equivalence - Clinical Evidence
N/A
### (b)(3). Substantial Equivalence - Conclusions
The design characteristics of the subject system do not raise any new types of questions of safety or effectiveness. From the evidence submitted in this 510(k), the subject devices can be expected to perform at least as well as the predicate device.
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.